Open Access Open Access  Restricted Access Subscription Access

Castleman Disease: A Rare Lymphoproliferative Disorder — A Comprehensive Review

Saleena Resheed

Abstract


A uncommon and diverse category of lymphoproliferative illnesses, Castleman disease (CD) is defined by aberrant lymphoid tissue proliferation with a range of clinical manifestations, histological characteristics, and prognoses. CD comprises distinct subtypes, broadly classified into unicentric Castleman disease (UCD) and multicentric Castleman disease (MCD), with further subclassifications based on viral association and clinical features. Despite advancements in understanding its pathogenesis and treatment, diagnosis remains challenging due to symptom overlap with other disorders. This article reviews current knowledge on CD, encompassing clinical characteristics, diagnosis, treatment, epidemiology, etiology, and potential avenues for further research.


Full Text:

PDF

References


Nishimura, M. F., Nishimura, Y., Nishikori, A., Yoshino, T., & Sato, Y. (2022). Historical and pathological overview of Castleman disease. Journal of Clinical and Experimental Hematopathology, 62(2), 60–72.

Gündüz, E., Özdemir, N., Bakanay, Ş. M., & Karakuş, S. (2021). A rare lymphoproliferative disease: Castleman disease. Turkish Journal of Haematology, 38(4), 314–320. https://doi.org/10.4274/tjh.galenos.2021.2021.0440

Cao, K. (2025). Recent progress in the clinical understanding, diagnosis, and treatment of Castleman disease. Clinical Lymphoma, Myeloma & Leukemia. Advance online publication. https://doi.org/10.54254/2753-8818/2025.SH25835

Patel, J. P., Patel, D. P., Amin, T. H., et al. (2024). Castleman disease: A rare lymphoproliferative disorder with diverse clinical presentation, diagnosis, and treatment approach. Cureus, 16(9), e69149. https://doi.org/10.7759/cureus.69149

Liu, Y. C., Stone, K., & van Rhee, F. (2014). Siltuximab for multicentric Castleman disease. Expert Review of Hematology, 7(5), 545–557. https://doi.org/10.1586/17474086.2014.946402

Recher, C., Fajgenbaum, D. C., et al. (2023). Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances. Blood Reviews.

Castleman disease. (2021). Nature Reviews Disease Primers, 7, 85. https://doi.org/10.1038/s41572-021-00323-9

Case report: Plasma cell variant of Castleman’s disease with bronchiolitis obliterans. (2023). Journal of Medical Case Reports.

Siltuximab in multicentric Castleman’s disease: Patient outcomes and impact. (2016). Journal for ImmunoTherapy of Cancer.

Wikipedia contributors. (2023). Castleman disease. In Wikipedia. https://en.wikipedia.org/wiki/Castleman_disease


Refbacks

  • There are currently no refbacks.